The pharmaceutical formulation manufacturing market in India is seeing rapid growth due to an increase in healthcare needs, growing export demand as well as evolving regulatory landscape. The country has become a major global centre for manufacturing high quality but affordable medicines for both local and overseas markets. The demand of pharmaceutical formulations is largely due to the growing population, the increasing awareness of healthcare and the shift towards preventive medicine. Manufacturers are innovating and enhancing the quality in the market, which is leading to surge in the production of tablets, capsules, injectables, and complex generics. Government incentives for self-reliance in the pharma industry have also bolstered domestic production capacity.

 The growth of the market is driven by India’s role as a major exporter of generic drugs. In fact, country’s pharmaceutical manufacturers have a good reputation in complying with global quality standards, thus they are considered to be reliable suppliers to international markets. Strategic collaborations, mergers and acquisitions also serve to the competitive landscape by increasing both companies' global footprint and enhancing their product portfolios. Like any field, the process of manufacturing has been affected by the advancements in technology and automation which thereby boost the process of efficiency, accuracy and scalability. Moreover, the growth of biosimilars, specialty drugs and value added formulations is also seen in the industry which is providing opportunity in growth. On the other hand, regulatory reforms and ease of approval processes are attracting investment into research and development that carry with them an increased focus on research and development in drug formulation. There are challenges within the industry such as pricing pressures, supply chain disruptions, and evolving regulatory requirements. To sustain the momentum, the main core will have to address these issues through strategic planning, infrastructure development and policy support. 

Keeping tabs on this market, India Pharma Outlook has shortlisted the select few companies in this field that have exhibited an unrelenting pursuit of excellence. By proving their dedication to fulfilling customer expectations and contributing to the market’s evolution through their innovative disposition, these firms are blazing a trail.  

We look forward to receiving your feedback and suggestions.